TargetMol

VK-II-86

Product Code:
 
TAR-T8965
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T8965-5mg5mg£318.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8965-10mg10mg£442.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8965-25mg25mg£734.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8965-50mg50mg£1,066.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
VK-II-86 is a non-β-blocking carvedilol analog. It prevents ouabain-Induced cardiotoxicity
CAS:
955371-84-3
Formula:
C25H28N2O4
Molecular Weight:
420.509
Purity:
0.98
SMILES:
COc1ccccc1OCCNCC(O)CCOc1cccc2[nH]c3ccccc3c12

References

Chakraborty A D , Gonano L A , Munro M L , et al. Activation of RyR2 by class I kinase inhibitors[J]. British Journal of Pharmacology, 2019, 176. Gonano L A , Sep?lveda, Marisa, Morell M , et al. Non-?-Blocking Carvedilol Analog, VK-II-86, Prevents Ouabain-Induced Cardiotoxicity[J]. Circulation Journal, 2018.